Bioaffinity Technologiew-27BIAFWPreferred / convertible
13F holders, Q1 2026 (March 31)4holders +1
1new positions
0sold out
1famous investor
$0.42avg. 13F price*
At the end of Q1 2026, 4 institutions reported holding Bioaffinity Technologiew-27 (BIAFW) in their 13F filings, up 1 from Q4 2025. 1 opened new positions and 0 sold out. The largest holders were Clear Street Group Inc. ($25K), UBS Group AG ($21K) and Citadel Advisors ($7K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bioaffinity Technologiew-27
- CUSIP
- 09076W117
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4K |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 11,013 shares bought and 4,202 shares sold, net +6,811 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Clear Street Group Inc. | — | Reduce -0.2% | 54,927 | $25K |
| UBS Group AG | — | Reduce -0.9% | 46,109 | $21K |
| Citadel Advisors | — | Reduce -15.5% | 19,850 | $7K |
| Susquehanna International Group, LLP | — | New | 11,013 | $4K |
"% of holder's portfolio" is BIAFW's weight in each manager's 13F, not the share of Bioaffinity Technologiew-27 the manager owns.